Graphical abstract Procedure Methyl (S)-2-((tert-Butoxycarbonyl)amino)-3-(7-(4,4,5,5-tetramethyl-1,3,2-dioxa-borolan-2-yl)-1H-indol-3-yl)propanoate (3)A flame-dried, 500-mL two-necked round-bottomed flask, equipped with a 3.5 cm footballshaped magnetic stir bar and thermometer, is charged with N-Boc-L-tryptophan methyl ester (1, 6.31 g, 19.8 mmol, 1.0 equiv), (1,5-cyclooctadiene)(methoxy)iridium(I) dimer (328 mg, 0.500 mmol, 0.025 equiv), and 4,4'-di-tert-butyl-2,2'-bipyridine (266 mg, 0.991 mmol, 0.05 equiv) (Note 1). The flask is sealed with a rubber septum secured by copper wire and placed under a nitrogen atmosphere after three successive vacuum-argon cycles conducted slowly using a needle inlet through the septum (Figure 1). Fresh anhydrous tetrahydrofuran (180 mL) (Note 2) is introduced into the flask via a syringe to afford a dark brown solution. Using a syringe, 4,4,5,5-tetramethyl-1,3,2-dioxaborolane (2, 14.4 mL, 99.1 mmol, 5.00 equiv) (Note 1) is added in a single portion, whereupon the solution rapidly changes color Checked by Danilo Pereira de Sant'Ana and Richmond Sarpong 1 N-Boc-L-Tryptophan methyl ester (99%) was used as purchased from Chem-Impex International, Inc. 4,4,5,5-Tetramethyl-1,3,2-dioxaborolane (97%), (1,5-cyclooctadiene)(methoxy)iridium(I) dimer and 4,4'-di-tert-butyl-2,2'-bipyridine (98%) were used as purchased from Sigma